CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity
CinPhloro Pharma, A CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for IBS-D
![Cinphloro clinical trial IBS-D](https://cinrx.com/wp-content/uploads/2024/02/web-tile-500x200-cinphloro-1.png)
CinPhloro Pharma Dosed First Participant in Phase 2 enviva Study of CIN-103 for IBS-D.
CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise.